Literature DB >> 19506818

Conceptus dose from involved-field radiotherapy for Hodgkin's lymphoma on a linear accelerator equipped with MLCs.

Michalis Mazonakis1, Efrossini Lyraraki, Charalambos Varveris, Elina Samara, Kyveli Zourari, John Damilakis.   

Abstract

PURPOSE: To estimate the scattered dose to conceptus from involved-field radiotherapy for Hodgkin's lymphoma on a linear accelerator equipped with multileaf collimators.
MATERIAL AND METHODS: Anthropomorphic phantoms were used to simulate an average pregnant woman at the 1st, 2nd and 3rd trimesters of gestation. Conceptus dose was measured using thermoluminescent dosimeters. Phantom measurements were performed for the minimum, medium and maximum field dimensions that may be employed during radiation therapy to lymph nodes in the neck, axilla, mediastinum and neck-mediastinum. The components of the scattered dose to conceptus were determined. Phantom exposures were generated with a 6-MV photon beam.
RESULTS: Neck irradiation with a tumor dose of 35 Gy resulted in a conceptus dose of 1.1-8.7 cGy depending upon the stage of pregnancy, the distance from treatment volume, and the field size applied. The corresponding conceptus dose ranges from radiotherapy in the regions of axilla, mediastinum and neck-mediastinum was 1.2-14.3 cGy, 3.7-57.7 cGy, and 5.1-91.8 cGy, respectively. The contribution of collimator scatter and head leakage to the total conceptus dose varied from 21% to 80% depending upon the irradiation site and gestational age.
CONCLUSION: The conceptus dose associated with cervical node irradiation is below the threshold value of 10 cGy during the entire pregnancy. Radiation therapy to lymph nodes in the axilla, mediastinum and neck-mediastinum may possibly lead to a conceptus dose of > 10 cGy and, therefore, informed decisions about the pregnancy termination should be made.

Entities:  

Mesh:

Year:  2009        PMID: 19506818     DOI: 10.1007/s00066-009-1932-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  28 in total

1.  A reduction in the AAPM TG-36 reported peripheral dose distributions with tertiary multileaf collimation. American Association of Physicists in Medicine Task Group 36.

Authors:  S Mutic; E E Klein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-01       Impact factor: 7.038

2.  Peripheral dose from a linear accelerator equipped with multileaf collimation.

Authors:  R L Stern
Journal:  Med Phys       Date:  1999-04       Impact factor: 4.071

3.  Radiotherapy of Hodgkin's disease in early pregnancy: embryo dose measurements.

Authors:  Michael Mazonakis; Haris Varveris; Maria Fasoulaki; John Damilakis
Journal:  Radiother Oncol       Date:  2003-03       Impact factor: 6.280

4.  [A special radiation shielding for the radiotherapy of a pregnant patient].

Authors:  Markus Buchgeister; Andre Mondry; Patrick Spillner; Frank Paulsen; Claus Belka; Michael Bamberg
Journal:  Strahlenther Onkol       Date:  2008-02       Impact factor: 3.621

5.  Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma.

Authors:  Hans Theodor Eich; Rolf-Peter Müller
Journal:  Strahlenther Onkol       Date:  2007-12       Impact factor: 3.621

6.  Modified radiation therapy regimen for Hodgkin's disease in the third trimester of pregnancy.

Authors:  J G Conley; A Jacobson
Journal:  AJR Am J Roentgenol       Date:  1977-04       Impact factor: 3.959

Review 7.  Coexistence of pregnancy and malignancy.

Authors:  Nicholas A Pavlidis
Journal:  Oncologist       Date:  2002

8.  Management of coexisting Hodgkin's disease and pregnancy.

Authors:  L Z Nisce; M A Tome; S He; B J Lee; G J Kutcher
Journal:  Am J Clin Oncol       Date:  1986-04       Impact factor: 2.339

9.  Scattered dose to gonads and associated risks from radiotherapy for common pediatric malignancies : a phantom study.

Authors:  Michalis Mazonakis; Fotini Zacharopoulou; Stefanos Kachris; Charalambos Varveris; John Damilakis; Nicholas Gourtsoyiannis
Journal:  Strahlenther Onkol       Date:  2007-06       Impact factor: 3.621

10.  A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk.

Authors:  Eng-Siew Koh; Tu Huan Tran; Mostafa Heydarian; Rainer K Sachs; Richard W Tsang; David J Brenner; Melania Pintilie; Tony Xu; June Chung; Narinder Paul; David C Hodgson
Journal:  Radiat Oncol       Date:  2007-03-15       Impact factor: 3.481

View more
  4 in total

1.  Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience.

Authors:  Domenico Genovesi; Giampiero Ausili Cèfaro; Annamaria Vinciguerra; Antonietta Augurio; Monica Di Tommaso; Rita Marchese; Umberto Ricardi; Andrea Riccardo Filippi; Theodore Girinsky; Katiuscia Di Biagio; Maurizio Belfiglio; Enza Barbieri; Vincenzo Valentini
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

2.  Hodgkin lymphoma in pregnancy.

Authors:  Veronika Bachanova; Joseph M Connors
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

3.  Treatment of Early Stages Hodgkin Lymphoma During Pregnancy.

Authors:  Agustin Avilés; Maria-Jesus Nambo; Natividad Neri
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-01-01       Impact factor: 2.576

4.  Calculation of organ doses from breast cancer radiotherapy: a Monte Carlo study.

Authors:  Theocharis Berris; Michael Mazonakis; John Stratakis; Antonios Tzedakis; Anastasia Fasoulaki; John Damilakis
Journal:  J Appl Clin Med Phys       Date:  2013-01-07       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.